{"id":49538,"date":"2022-10-12T14:01:56","date_gmt":"2022-10-12T12:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/"},"modified":"2022-10-12T14:01:56","modified_gmt":"2022-10-12T12:01:56","slug":"triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/","title":{"rendered":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022"},"content":{"rendered":"<div>\n<p>AUSTIN, Texas, &amp; HAMILTON, Ontario&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftriumvira.com%2F&amp;esheet=52942026&amp;newsitemid=20221012005104&amp;lan=en-US&amp;anchor=Triumvira+Immunologics&amp;index=1&amp;md5=9f92d04949e46f0b90d8cf2266b33a5e\" rel=\"nofollow noopener\" shape=\"rect\">Triumvira Immunologics<\/a> (\u201cTriumvira\u201d), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors,<b> <\/b>today announced that Senior Management will participate in four upcoming healthcare investor conferences.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/5\/LOGO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nOppenheimer Private Company Showcase: The Next Wave: presentation at 2:35 pm PT on Tuesday, October 18<sup>th<\/sup> and available for investor meetings\n<\/li>\n<li>\nBank of America Healthcare Life Sciences Private Company Conference: available for in-person investor meetings on Thursday, October 20<sup>th<\/sup>\n<\/li>\n<li>\nWells Fargo Private Biotech Symposium: available for virtual investor meetings on Wednesday, November 2<sup>nd<\/sup>\n<\/li>\n<li>\nStifel 2022 Healthcare Conference: presentation on Wednesday, November 16<sup>th<\/sup> at 9:10 am ET and available for investor meetings\n<\/li>\n<\/ul>\n<p>\n<b>About Triumvira Immunologics<br \/>\n<br \/><\/b>Triumvira is a clinical-stage company developing a best-in-class, rationally designed cell therapy platform based on its proprietary T cell Antigen Coupler (TAC) technology. Its lead candidate, TAC01-HER2, is being evaluated in an ongoing Phase 1\/2 trial for HER2-positive solid tumors with positive initial safety and efficacy data to-date. Triumvira\u2019s pipeline includes other compelling pre-clinical solid tumor programs targeting Claudin 18.2, GUCY2C and GPC3, among others, with anticipated IND filings over the next few years. Supporting the pipeline has been an industrialized, drug-like, approach to manufacturing, including the first-mover adoption of the Lonza Cocoon\u00ae Platform that has yielded high quality product and a very high manufacturing success rate at a lower cost compared to other autologous approaches. Building on the proof-of-concept of its clinical-stage autologous TAC01-HER2 program, Triumvira is continuing to develop and advance its gamma delta allogeneic pipeline with IND filings anticipated over the next three years.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Relations:<\/b><br \/>Stephanie Carrington<br \/>\n<br \/>ICR Westwicke<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#83;&#116;e&#x70;&#x68;&#97;&#110;i&#x65;&#x2e;&#x43;&#97;rr&#x69;&#x6e;&#103;&#116;o&#x6e;&#x40;&#119;&#101;s&#x74;&#x77;&#105;&#99;k&#x65;&#x2e;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">St&#101;&#112;&#104;&#x61;&#x6e;&#x69;&#x65;&#x2e;Ca&#114;&#114;&#105;&#x6e;&#x67;&#x74;&#x6f;&#x6e;&#64;w&#101;&#115;&#116;&#x77;&#x69;&#x63;&#x6b;&#x65;&#46;c&#111;&#109;<\/a><br \/>646-277-1282<\/p>\n<p><b>Media Relations:<\/b><br \/>Karen Chase<br \/>\n<br \/>ICR Westwicke<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#75;a&#x72;&#101;n&#x2e;&#67;h&#x61;&#115;e&#x40;&#119;e&#x73;&#116;w&#x69;&#99;k&#x65;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x4b;&#97;r&#x65;&#110;&#46;&#x43;&#x68;&#97;s&#x65;&#64;w&#x65;&#x73;&#116;w&#x69;&#99;k&#x65;&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, &amp; HAMILTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Triumvira Immunologics (\u201cTriumvira\u201d), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that Senior Management will participate in four upcoming healthcare investor conferences. Oppenheimer Private Company Showcase: The Next Wave: presentation &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49538","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, &amp; HAMILTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Triumvira Immunologics (\u201cTriumvira\u201d), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that Senior Management will participate in four upcoming healthcare investor conferences. Oppenheimer Private Company Showcase: The Next Wave: presentation ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-12T12:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022\",\"datePublished\":\"2022-10-12T12:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/\"},\"wordCount\":307,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005104\\\/en\\\/1598372\\\/21\\\/LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/\",\"name\":\"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005104\\\/en\\\/1598372\\\/21\\\/LOGO.jpg\",\"datePublished\":\"2022-10-12T12:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005104\\\/en\\\/1598372\\\/21\\\/LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005104\\\/en\\\/1598372\\\/21\\\/LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/","og_locale":"en_US","og_type":"article","og_title":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend","og_description":"AUSTIN, Texas, &amp; HAMILTON, Ontario&#8211;(BUSINESS WIRE)&#8211;Triumvira Immunologics (\u201cTriumvira\u201d), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors, today announced that Senior Management will participate in four upcoming healthcare investor conferences. Oppenheimer Private Company Showcase: The Next Wave: presentation ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-12T12:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022","datePublished":"2022-10-12T12:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/"},"wordCount":307,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/","url":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/","name":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg","datePublished":"2022-10-12T12:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221012005104\/en\/1598372\/21\/LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/triumvira-immunologics-to-participate-in-four-upcoming-healthcare-investor-conferences-in-october-and-november-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Triumvira Immunologics to Participate in Four Upcoming Healthcare Investor Conferences in October and November 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49538"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49538\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}